Ajax Health Launches a New Investment Fund

Want to share this story?

Ajax Health, which invests in disruptive technologies in healthcare, announced it raised $100 million to form its third fund, Ajax 3. The capital will be used to invest in companies specializing in med-tech, healthcare services and healthcare tech that focuses on innovative approaches to addressing major issues in healthcare.

HealthQuest Capital led the funding, with participation from Polaris Partners.

“Ajax represents a unique opportunity for HealthQuest to deploy capital at scale by investing in a platform where we have very strong conviction in the team,” said Garheng Kong, MD, PhD, HealthQuest’s founder and managing partner, in a statement.  “We are continuing to build a long-term partnership where our capital and network will complement Duke and the Ajax team’s incredible operational acumen to catalyze innovative medical companies.”

“We are excited about the progress of Ajax 2 companies and are thrilled to continue our partnership with Garheng and HealthQuest, as well as Polaris,” said Duke Rohlen, Chairman and CEO of Menlo Park based Ajax Health. “The HealthQuest team has been integral to the momentum Ajax 2 has built to date and we look forward to continuing to leverage its expertise to identify and execute on new opportunities for Ajax 3.”

The last funding round Ajax health received prior to this one was $100 million previously raised in April 2019 for Ajax 2.